SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-062445
Filing Date
2021-05-06
Accepted
2021-05-06 16:31:41
Documents
14
Period of Report
2021-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2115341d1_8k.htm   iXBRL 8-K 25735
2 EXHIBIT 99.1 tm2115341d1_ex99-1.htm EX-99.1 52076
6 GRAPHIC image_001.jpg GRAPHIC 6850
  Complete submission text file 0001104659-21-062445.txt   270948

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ckpt-20210506.xsd EX-101.SCH 3199
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ckpt-20210506_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ckpt-20210506_pre.xml EX-101.PRE 22719
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2115341d1_8k_htm.xml XML 3726
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38128 | Film No.: 21898364
SIC: 2834 Pharmaceutical Preparations